Figueira-Gonçalves, J., Alcázar-Navarrete, B., Casitas-Mateo, R., González, J., Gotera-Rivera, C., Herrejón-Silvestre, A., . . . Sánchez-Covisa, J. (2026). Real-World Outcomes in Patients with COPD Initiating Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate After Dual and Triple Therapy in Spain: A Sub-Study of the ORESTES Study.
Citación estilo ChicagoFigueira-Gonçalves, JM, et al. Real-World Outcomes in Patients With COPD Initiating Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate After Dual and Triple Therapy in Spain: A Sub-Study of the ORESTES Study. 2026.
Cita MLAFigueira-Gonçalves, JM, et al. Real-World Outcomes in Patients With COPD Initiating Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate After Dual and Triple Therapy in Spain: A Sub-Study of the ORESTES Study. 2026.